The Value of Pancreatic Stone Protein in Predicting Acute Appendicitis
1 other identifier
observational
245
1 country
2
Brief Summary
PSP (Pancreatic Stone Protein) is a compound naturally produced mainly in the pancreas and the gut. There is evidence from experimental and clinical trials that the levels of PSP in the blood rise in the presence of inflammation or infection. What is not yet well known about PSP is whether it is superior to other established blood tests (e.g. WBC or CRP) in predicting appendicitis in patients that present at the emergency room with abdominal pain and a clinical suspicion of appendicitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2012
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 30, 2012
CompletedFirst Posted
Study publicly available on registry
June 1, 2012
CompletedStudy Start
First participant enrolled
June 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2014
CompletedAugust 23, 2013
August 1, 2013
1.5 years
May 30, 2012
August 22, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Accuracy of PSP in diagnosing appendicitis
ROC Curve analysis and predictive value of PSP (Pancreatic Stone Protein) in diagnosing appendicitis
1 day
Secondary Outcomes (5)
Accuracy of CRP in diagnosing appendicitis
1 day
Accuracy of WCC in diagnosing appendicitis
1 day
Accuracy of the "Alvarado Score" in diagnosis appendicitis
1 day
Accuracy of USS in diagnosing appendicitis
1 day
Accuracy of CT in diagnosing appendicitis
1 day
Other Outcomes (1)
Independent predictors of appendicitis
1 day
Study Arms (1)
Right sided abdominal pain
Patients that present at the Emergency Department with abdominal pain and a clinical suspicion of appendicitis.
Interventions
Also known as appendectomy, surgical removal of the appendix. Laparoscopic (single or 4 port), McBurney's incision, mid-line laparotomy, laparoscopic converted to open.
Eligibility Criteria
All patients that will present at the emergency department with abdominal pain and a clinical suspicion of acute appendicitis.
You may qualify if:
- Age \>18 years of age (subject to the current ethics approval protocol, may change)
- Clinical suspicion of appendicitis as the primary or differential diagnoses
- Patients able to provide informed consent
You may not qualify if:
- Age \<18 years of age (subject to the current ethics approval protocol, may change)
- Abdominal discomfort without tenderness or rebound or clinical suspicion of appendicitis
- Pregnancy
- Patients with impaired consciousness
- Patients not able to provide informed consent
- Patients that will receive an appendicectomy as part of another elective procedure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Zurichlead
- Laikο General Hospital, Athenscollaborator
- University of Athenscollaborator
- Kantonsspital Münsterlingencollaborator
Study Sites (2)
University Hospital Zurich
Zurich, Canton of Zurich, 8091, Switzerland
University Hospital Zurich, Department of Surgery
Zurich, CH-8091, Switzerland
Related Publications (9)
Alvarado A. A practical score for the early diagnosis of acute appendicitis. Ann Emerg Med. 1986 May;15(5):557-64. doi: 10.1016/s0196-0644(86)80993-3.
PMID: 3963537BACKGROUNDClavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibanes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009 Aug;250(2):187-96. doi: 10.1097/SLA.0b013e3181b13ca2.
PMID: 19638912BACKGROUNDBoeck L, Graf R, Eggimann P, Pargger H, Raptis DA, Smyrnios N, Thakkar N, Siegemund M, Rakic J, Tamm M, Stolz D. Pancreatic stone protein: a marker of organ failure and outcome in ventilator-associated pneumonia. Chest. 2011 Oct;140(4):925-932. doi: 10.1378/chest.11-0018. Epub 2011 Aug 11.
PMID: 21835904BACKGROUNDKeel M, Harter L, Reding T, Sun LK, Hersberger M, Seifert B, Bimmler D, Graf R. Pancreatic stone protein is highly increased during posttraumatic sepsis and activates neutrophil granulocytes. Crit Care Med. 2009 May;37(5):1642-8. doi: 10.1097/CCM.0b013e31819da7d6.
PMID: 19325491BACKGROUNDGraf R, Schiesser M, Reding T, Appenzeller P, Sun LK, Fortunato F, Perren A, Bimmler D. Exocrine meets endocrine: pancreatic stone protein and regenerating protein--two sides of the same coin. J Surg Res. 2006 Jun 15;133(2):113-20. doi: 10.1016/j.jss.2005.09.030. Epub 2005 Dec 19.
PMID: 16360171BACKGROUNDBimmler D, Graf R, Scheele GA, Frick TW. Pancreatic stone protein (lithostathine), a physiologically relevant pancreatic calcium carbonate crystal inhibitor? J Biol Chem. 1997 Jan 31;272(5):3073-82. doi: 10.1074/jbc.272.5.3073.
PMID: 9006958BACKGROUNDPlanas R, Pujol-Autonell I, Ruiz E, Montraveta M, Cabre E, Lucas-Martin A, Pujol-Borrell R, Martinez-Caceres E, Vives-Pi M. Regenerating gene Ialpha is a biomarker for diagnosis and monitoring of celiac disease: a preliminary study. Transl Res. 2011 Sep;158(3):140-5. doi: 10.1016/j.trsl.2011.04.004. Epub 2011 May 30.
PMID: 21867979BACKGROUNDJin CX, Hayakawa T, Ko SB, Ishiguro H, Kitagawa M. Pancreatic stone protein/regenerating protein family in pancreatic and gastrointestinal diseases. Intern Med. 2011;50(15):1507-16. doi: 10.2169/internalmedicine.50.5362. Epub 2011 Aug 1.
PMID: 21804274BACKGROUNDTschuor C, Raptis DA, Limani P, Bachler T, Oberkofler CE, Breitenstein S, Graf R. The value of pancreatic stone protein in predicting acute appendicitis in patients presenting at the emergency department with abdominal pain. BMC Gastroenterol. 2012 Oct 25;12:154. doi: 10.1186/1471-230X-12-154.
PMID: 23098130DERIVED
Biospecimen
Whole blood and serum or plasma of 245 patients.
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dimitri A Raptis, MD, MSc
University Hospital Zurich, Department of Surgery
- STUDY CHAIR
Rolf Graf, PhD
University Hospital Zurich, Department of Surgery
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 30, 2012
First Posted
June 1, 2012
Study Start
June 1, 2012
Primary Completion
December 1, 2013
Study Completion
January 1, 2014
Last Updated
August 23, 2013
Record last verified: 2013-08